Name: Denik Pharma Insugro DS (IGF-1 DES) | Advanced Growth
Price: 11499.00 INR
Availability: InStock

Denik Pharma Insugro DS (IGF-1 DES) | Advanced Growth

IGF1 DES (Somatomedin C)

Vial: 1 mg

Ampoule: 2 mL Sterile Water for Injection

Form: Lyophilised Powder

Administration: Subcutaneous (SC) or Intramuscular (IM) after reconstitution

⸻

Product Overview

INSUGRO-DS by Denik Pharma contains IGF1 DES (Insulin-Like Growth Factor-1 DES, also known as Somatomedin C) — a modified, short-acting analog of the endogenous IGF-1 hormone. IGF-1 is a naturally occurring growth factor that plays a central role in cell growth, tissue repair, protein synthesis, and metabolic regulation.

IGF1 DES is engineered for enhanced receptor binding and localized activity, making it an attractive peptide in research environments focused on tissue regeneration, muscle repair, and targeted anabolic effects.

⸻

How INSUGRO-DS Works

IGF-1 DES binds to IGF-1 receptors on cells throughout the body, activating intracellular signaling pathways that:

•Enhance cellular growth and regeneration

•Promote protein synthesis and tissue repair

•Support nutrient uptake and glucose utilization

•Encourage anabolic processes in muscle and connective tissues

Because it is rapidly cleared from circulation, IGF-1 DES’s effects are often more localized and intense compared with longer-acting IGF-1 analogs.

⸻

Potential Benefits

✔ Enhanced Tissue Repair & Regeneration

IGF1 DES may accelerate healing of muscle, tendon, and connective tissue, especially when applied near injured or targeted regions, supporting recovery protocols.

✔ Promotes Protein Synthesis & Anabolism

By activating IGF-1 receptors, INSUGRO-DS can help support cellular growth and protein building, contributing to improved structural maintenance in research scenarios.

✔ Targeted Muscle Density and Hardness

Localized IGF-1 DES activity may support denser, firmer muscle fibers when combined with mechanical stimulus such as resistance training.

✔ Supports Glucose Utilization

IGF-1 has an “insulin-like” effect, potentially enhancing glucose uptake and metabolic efficiency in cells.

✔ Lower Systemic Exposure

Due to its shorter half-life compared with longer IGF-1 analogs, INSUGRO-DS generally affects local tissues with reduced sustained systemic receptor activation.

Note: These benefits are associated with peptide research settings and protocols used under professional oversight. Individual results and responses can vary.

⸻

Common Side Effects

IGF-1 DES is generally considered to have a lower systemic side effect profile than longer-acting IGF-1 analogs, but some effects still may occur, especially at the injection site:

•Redness or swelling at injection site

•Mild localized irritation

•Temporary soreness or muscle tenderness

•Mild headache or fatigue

These effects often resolve shortly after injection.

⸻

Less Common / Possible Side Effects

Because IGF-1 DES interacts with growth factor pathways, less common systemic issues can occur:

•Hypoglycemia (low blood sugar): IGF-1’s insulin-like action can promote glucose entry into cells, potentially lowering blood sugar, especially if injected without adequate nutrition.

•Fluid retention or mild joint stiffness: May occur when peptides influence cellular growth mechanisms.

•Localized injection site inflammation: More common with repeated injections in the same area.

⸻

Safety & Important Considerations

•Medical or Research Use Only: INSUGRO-DS should be used under the guidance of a qualified healthcare or research professional.

•Not Approved for General Use: IGF-1 DES is not approved by most major regulatory agencies for therapeutic use outside controlled research contexts.

•Blood Sugar Monitoring: Because IGF-1 mimics some effects of insulin, monitoring blood glucose — especially around dosing — is advised.

•Cell Growth Concerns: IGF-1 signaling promotes cell proliferation; individuals with a history of cancer or active tumors should avoid use due to potential growth-stimulatory effects.

•Proper Protocols Required: Follow reconstitution, dosing, and injection site rotation protocols to reduce risk of irritation and ensure peptide stability.

⸻

Storage Instructions

•Before reconstitution: Store vials refrigerated at 2–8 °C.

•After reconstitution: Use as advised — typically within a defined timeframe — and store under recommended conditions to maintain integrity.

•Do not freeze after reconstitution.

⸻

Summary

Denik Pharma — INSUGRO-DS (IGF1 DES / Somatomedin C, 1 mg) is a short-acting IGF-1 analog designed to support localized tissue repair, anabolic signaling, and protein synthesis through IGF-1 receptor activation. With rapid receptor engagement and a targeted action profile, it’s commonly used in research environments focused on regeneration and recovery. While generally well-tolerated for short durations, users should be aware of hypoglycemia risk, injection site reactions, and cellular growth implications, and always use the product with professional oversight.

💳 Payment Options

Prepaid Orders: ✔ Free Delivery
Cash on Delivery (COD) :
- 25% advance payment required
- ₹300 COD shipping charge

(Advance payment helps us avoid fake orders and ensures faster dispatch.)

⏱️ Dispatch & Delivery

Dispatch Time: 24–48 working hours
Delivery: Pan-India coverage
Estimated Delivery:
Metro Cities: 2–4 working days
Other Locations: 3–7 working days
(Delivery time may vary due to location, weather, or courier delays.)
Tracking: Shared via WhatsApp / SMS after dispatch
❗ Important Delivery Notes
Please ensure your address and contact number are accurate
Orders once shipped cannot be cancelled or redirected
Refused or unclaimed COD orders may affect future COD eligibility

📦 Packaging & Privacy

🔒 Tamper-proof sealed packaging
🕶️ Discreet outer box
🔐 100% customer privacy maintained

🚛 Trusted Courier Partners

We ship only through reliable national courier services:

DTDC
Blue Dart
Ekart
Delhivery

🛡️ Trust & Assurance

✔ 100% Genuine Products

✔ Verified & Trusted Seller

✔ Secure Delivery Network

✔ Pan-India Shipping

Denik Pharma Insugro DS (IGF-1 DES) | Advanced Growth

Denik Pharma Insugro DS (IGF-1 DES) | Advanced Growth

Brand